CODX - Co-Diagnostics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Co-Diagnostics, Inc.

2401 South Foothill Drive
Suite D
Salt Lake City, UT 84109
United States
801-438-1036
http://www.codiagnostics.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees29

Key Executives

NameTitlePayExercisedYear Born
Mr. Dwight H. EganChairman, CEO & Pres295kN/A1953
Dr. Brent C. SatterfieldCo-Founder & Chief Science Officer237.5kN/A1977
Mr. Reed L. BensonCFO & Sec.215kN/A1948
Dr. Mayuranki AlmaulaSr. VP of Overseas Operations & Strategic AlliancesN/AN/AN/A
Mr. Cameron GundryHead of Commercialization LATAM/EURN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.

Corporate Governance

Co-Diagnostics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.